Company: REVB
Filing Date: 2025-05-23
Form Type: S-1/A
Source: 0001213900-25-047104
Chunk: 61

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-23
Form: S-1/A
Chunk 61
---
 Care Act to a stricter standard such that a person or entity no longer needs to have actual knowledge of the statute or   
 specific intent to violate it in order to have committed a violation. Moreover, the government may assert that a claim including items   
 or services resulting from violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the    
 FCA.                                                                                                                                     |

| ● | The federal HIPAA, which prohibits, among other things, knowingly                                                                         
 and willfully executing, or attempting to execute, a scheme or artifice to defraud any healthcare benefit program or obtain, by means     
 of false or fraudulent pretenses, representations, or promises, any of the money or property owned by, or under the custody or control    
 of, any healthcare benefit program, regardless of the payor (e.g., public or private), willfully obstructing a criminal investigation     
 of a healthcare offense, and knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or      
 making any materially false, fictitious or fraudulent statements in connection with the delivery of, or payment for, healthcare benefits, 
 items or services relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have  
 actual knowledge of the statute or specific intent to violate it in order to have committed a violation.                                  |

| ● | Patient data privacy and security regulation, including,                                                                                         
 in the United States, HIPAA, as amended by the Health Information Technology for Clinical Health Act of 2009 (“HITECH”),                         
 and their respective implementing regulations, which impose specified requirements on “covered entities,” including healthcare                   
 providers, health plans, and healthcare clearinghouses, as well as their respective “business associates” that perform services                  
 for them that involve the use, or disclosure of, individually identifiable health information relating to the privacy, security and transmission 
 of individually identifiable health information.                                                                                                 |

| ● | The federal transparency requirements under the Physician                                                                                     
 Payments Sunshine Act, enacted as part of the Affordable Care Act, that require applicable manufacturers of covered drugs, devices, biologics 
 and medical supplies for which payment is available under Medicare, Medicaid, or the Children’s Health Insurance Program, with                
 specific exceptions, to track and annually report to CMS payments and other transfers of value provided to physicians and teaching hospitals  
 and certain ownership and investment interests held by physicians or their immediate family members in the applicable manufacturer, and       
 disclosure of such information will